Open
SectorHealthcare
12.44 -1.66
24h
Min
12.13
Max
12.97
Income | -10M -94M |
---|---|
Sales | -4.8M 7.7M |
EPS | -1.1 |
Profit margin | -1,226.159 |
Employees | 270 |
EBITDA | -5.3M -89M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +179.65% upside |
Next Earnings | 7 May 2025 |
---|
Market Cap | -188M 1.1B |
---|---|
Previous open | 14.1 |
Previous close | 12.44 |
By Acuity
11%
89%
10 / 386 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 36.27 USD 179.65%
High 51 USD
Low 16 USD
Based on 13 Wall Street analysts offering 12 month price targets forSyndax Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$